Characterization of Cycloartane-Type Sapogenol Derivatives for Prostate Cancer Chemoprevention†
AbstractInhibition of inflammation-induced carcinogenesis is an efficient therapeutic strategy for cancer chemoprevention as use of anti-inflammatories was reported to decrease the cancer risk. In this study, we aimed to investigate the inhibition potential of semi-synthetic derivations of cycloartane-type sapogenol molecules on inflammation-related tumorigenic mechanisms in LNCaP prostate cancer cells. Inflammatory microenvironment was stimulated by TNFα/inflammatory conditioned media (CM). WST1/Xcelligence (proliferation), luciferase reporter (NFkB activity), immunoblotting, DCFH (ROS) and Griess (NO release) methods were used. It has been found that TNFα-induced NFkB activation was suppressed by both astragenol and cycloastragenol derivatives through inhibition of IkB phosphorylation. Further, the loss of Androgen Receptor, NKX3.1 and p53 due to inflammatory microenvironment was partially restored. In addition, tumorigenic cellular events such as increased NO release and intracellular ROS levels were both suppressed by the molecules. Inhibition of B-catenin pathway at anti-inflammatory concentrations was determined through decreased levels of pAkt(S473), total B-catenin and B-catenin(S552) induced by both lipopolysaccharide and CM treatments in inflammatory microenvironment. Finally, saponin molecules were found to suppress the proliferation and migration of prostate cancer cells at apoptotic concentrations. Therefore, it is suggested that anti-inflammatory activity of these sapogenol derivatives through NFkB inhibition make them promising agents for chemoprevention of inflammation-related prostate carcinogenesis.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Debelec-Butuner, B.; Ozturk, M.B.; Tag, O.; Akgun, I.H.; Bedir, E.; Korkmaz, K.S. Characterization of Cycloartane-Type Sapogenol Derivatives for Prostate Cancer Chemoprevention. Proceedings 2017, 1, 985.
Debelec-Butuner B, Ozturk MB, Tag O, Akgun IH, Bedir E, Korkmaz KS. Characterization of Cycloartane-Type Sapogenol Derivatives for Prostate Cancer Chemoprevention. Proceedings. 2017; 1(10):985.Chicago/Turabian Style
Debelec-Butuner, Bilge; Ozturk, Mert Burak; Tag, Ozgur; Akgun, Ismail Hakki; Bedir, Erdal; Korkmaz, Kemal Sami. 2017. "Characterization of Cycloartane-Type Sapogenol Derivatives for Prostate Cancer Chemoprevention." Proceedings 1, no. 10: 985.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.